Genotypic Prediction of Co-receptor Tropism of HIV-1 Subtypes A and C

Abstract

Antiretroviral treatment of Human Immunodeficiency Virus type-1 (HIV-1) infections with CCR5-antagonists requires the co-receptor usage prediction of viral strains. Currently available tools are mostly designed based on subtype B strains and thus are in general not applicable to non-B subtypes. However, HIV-1 infections caused by subtype B only account for approximately 11% of infections worldwide. We evaluated the performance of several sequence-based algorithms for co-receptor usage prediction employed on subtype A V3 sequences including circulating recombinant forms (CRFs) and subtype C strains. We further analysed sequence profiles of gp120 regions of subtype A, B and C to explore functional relationships to entry phenotypes. Our analyses clearly demonstrate that state-of-the-art algorithms are not useful for predicting co-receptor tropism of subtype A and its CRFs. Sequence profile analysis of gp120 revealed molecular variability in subtype A viruses. Especially, the V2 loop region could be associated with co-receptor tropism, which might indicate a unique pattern that determines co-receptor tropism in subtype A strains compared to subtype B and C strains. Thus, our study demonstrates that there is a need for the development of novel algorithms facilitating tropism prediction of HIV-1 subtype A to improve effective antiretroviral treatment in patients.

The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma

“…We used cutoffs of 10 ng/mL and 20 ng/mL for AFP, 10 % for AFP-L3, 7.5 ng/mL for DCP, and −0.63 for the GALAD score. For direct comparison of the resulting models, we calculated the diagnostic odds ratio (DOR) as described by Riemenschneider et al [21]. The DOR is defined as follows:…”

HIV-1 subtype C predicted co-receptor tropism in Africa: an individual sequence level meta-analysis

“…Sub-classifications included early chronic infection (186 days to 1 year post infection) and late chronic infections (> 5 years post infection). Sequences were separately analysed for predicted co-receptor preferences Phenoseq-C and PSSMsinsi are particularly HIV-1-C based co-receptor prediction tools [36][37][38][39]. An inferred concordance of all three tools was used to assign the coreceptor biotype.…”

Editorial: Artificial Intelligence Bioinformatics: Development and Application of Tools for Omics and Inter-Omics Studies

“…Machine learning, statistical learning, and soft-computing approaches, such as deep neural networks or genetic algorithms, have also become terms used in the bio world, with an incomplete comprehension however, of their potential (Pavel et al, 2016;Lin and Lane, 2017;Zeng and Lumley, 2018). In recent years, omics, multi-omics, and inter-omics experiments have presented a further step toward the investigation in biology, opening the window on personalized medicine, for example for diagnostics (Riemenschneider et al, 2016). The era of big data in medicine is imminent and represents yet a further step forward.…”